Hossein Nejadnik

Hossein Nejadnik

Auto-generated profile, based on publicly available information

Hossein Nejadnik

Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA 19104

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
LKLouise Kiru
Louise Kiru
AZAimen Zlitni
Aimen Zlitni
ATAidan Michael Tousley
Aidan Michael Tousley
GDGuillermo Nicolás Dalton
Guillermo Nicolás Dalton
WWWei Wu
Wei Wu
HDHeike E Daldrup-Link
Heike E Daldrup-Link
Significance: Chimeric antigen receptor (CAR) T-cell therapy is approved by the US Food and Drug Administration (FDA) for the treatment of B-cell acute lymphoblastic leukemia. Efforts are now underway to evaluate the efficacy of CAR T-cell therapy in solid tumors. However, a key limitation in the advancement of T-cell therapy is the lack of information on the biodistribution of the T cells in patients. Therefore, there is a need for the identification of translatable methods for tracking the therapeutic T cells noninvasively. We describe the mechanical labeling of CAR T cells with an FDA-approved iron oxide nanoparticle to demonstrate the noninvasive and multimodal imaging of the CAR T cells. This method may be utilized for monitoring T cells in clinical trials.

1 September 2012 in Radiology
Verified
Journal Article
Open access
AKAman Khurana
Aman Khurana
HNHossein Nejadnik
Hossein Nejadnik
RGRakhee Gawande
Rakhee Gawande
GLGuiting Lin
Guiting Lin
SLSungmin Lee
Sungmin Lee
HDHeike E Daldrup-Link
Heike E Daldrup-Link
The macrophage tracking technique presented could reveal differential macrophage accumulation in viable versus apoptotic matrix-associated stem cell implants and could potentially also be applied f... PurposeTo develop a clinically applicable imaging technique for monitoring differential migration of macrophages into viable and apoptotic matrix-associated stem cell implants (MASIs) in arthritic ...

1 July 2019 in Radiology
Verified
Journal Article
Closed access
ATAshok J. Theruvath
Ashok J. Theruvath
HNHossein Nejadnik
Hossein Nejadnik
OLOlga Lenkov
Olga Lenkov
KYKetan Yerneni
Ketan Yerneni
KLKai Li
Kai Li
HDHeike E Daldrup-Link
Heike E Daldrup-Link
Ferumoxytol-labeled matrix-associated stem cell implants can predict cartilage repair outcomes with MRI in a large-animal model. BackgroundCartilage repair outcomes of matrix-associated stem cell implants (MASIs) in patients have been highly variable. Conventional MRI cannot help distinguish between grafts that will and graf...

5 September 2018 in Molecular Imaging and Biology
Verified
Journal Article
Open access
ALArian Pourmehdi Lahiji
Arian Pourmehdi Lahiji
TJTatianie Jackson
Tatianie Jackson
HNHossein Nejadnik
Hossein Nejadnik
RERie von Eyben
Rie von Eyben
DRDaniel Rubin
Daniel Rubin
HDHeike E Daldrup-Link
Heike E Daldrup-Link
Purpose To evaluate whether the extent of restricted diffusion and 2-deoxy-2-[18F] fluoro-d-glucose ([18F]FDG) uptake of pediatric rhabdomyosarcomas (RMS) on positron emission tomography (PET)/magnetic resonance (MR) images provides prognostic information. Procedure In a retrospective, IRB-approved study, we evaluated [18F]FDG PET/CT and diffusion-weighted (DW) MR imaging studies of 21 children and adolescents (age 1–20 years) with RMS of the head and neck. [18F]FDG PET and DW MR scans at the time of the initial tumor diagnosis were fused using MIM software. Quantitative measures of the tumor mass with restricted diffusion, [18F]FDG hypermetabolism, or both were dichotomized at the median and tested for significance using Gray’s test. Data were analyzed using a survival analysis and competing risk model with death as the competing risk. Results [18F]FDG PET/MR images demonstrated a mismatch between tumor areas with increased [18F]FDG uptake and restricted diffusion. The DWI, PET, and DWI + PET tumor volumes were dichotomized at their median values, 23.7, 16.4, and 9.5 cm3, respectively, and were used to estimate survival. DWI, PET, and DWI + PET overlap tumor volumes above the cutoff values were associated with tumor recurrence, regardless of post therapy COG stage (p = 0.007, p = 0.04, and p = 0.07, respectively). Conclusion The extent of restricted diffusion within RMS and overlap of hypermetabolism plus restricted diffusion predict unfavorable clinical outcomes.